Analysis of Codon Bias on Clostridium Perfringens Del1 Genome
- DOI
- 10.2991/bst-17.2018.20How to use a DOI?
- Keywords
- Clostridium perfringens, Codon usage bias, Correspondence analysis, Optimal codon.
- Abstract
Clostridium perfringens is a conditional pathogen, which widely exists in the nature water, soil, intestinal tract, and serious threat to public health and safety. In this study, the codon usage of Clostridium perfringens was examined. CDS sequences of 2744 high confidence protein coding genes were selected from Clostridium perfringens Genome Database. Their GC content of these genes ranged from 14.7% to 41.9%, with the average of 29.9% for whole genome. The frequency of G or C in the third position of synonymous codon was 25.6%, which was lower than that of A or T. The effective number of codon(ENC) of Clostridium perfringens genome ranged from 26.9 to 61.0,with the average of 39.9. Clostridium perfringens prefer codons ending in A/T. The ENC values of each gene significantly positive correlated with its C3s, G3s, GC3s and GC content (r=0.674, 0.738, 0.780 and 0.368, respectively, p<0.01). However, ENC showed significant negative correlations with T3s, A3s and CAI (r=-0.668, -0.688 and -0.255, respectively, p<0.01). A total of 27 optimal codons were found from Clostridium perfringens genome, all of which the third position of synonymous codon was A or T.
- Copyright
- © 2018, the Authors. Published by Atlantis Press.
- Open Access
- This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Cite this article
TY - CONF AU - Lin Chen AU - Ting Bai AU - Wei Wang AU - Tian-Fei Liu AU - Li-Li Ji AU - Jia-Min Zhang PY - 2018/02 DA - 2018/02 TI - Analysis of Codon Bias on Clostridium Perfringens Del1 Genome BT - Proceedings of the 2017 2nd International Conference on Biological Sciences and Technology (BST 2017) PB - Atlantis Press SP - 134 EP - 141 SN - 2468-5747 UR - https://doi.org/10.2991/bst-17.2018.20 DO - 10.2991/bst-17.2018.20 ID - Chen2018/02 ER -